Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Polycystic Ovary Syndrome 3Peripheral Nervous System Diseases 2Obesity 2Neoplasms 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Triple Negative Breast Neoplasms 1Tracheal Diseases 1TP53 Y220C Mutation 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Pancreatic Neoplasms 1Overweight 1Osteosarcoma 1Neuroblastoma 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Motor Activity 1Mesothelioma 1Meningioma 1Medulloblastoma 1

Interventions

Echocardiography 6Doxorubicin 3Carvedilol 3empagliflozin 2Social Determinants of Health 2Electrocardiography 2Cyclophosphamide 2pegfilgrastim 1dapagliflozin 1Watchful Waiting 1Vincristine 1Vascular Stiffness 1Trastuzumab 1Tablets 1Standard of Care 1Rosuvastatin Calcium 1Rituximab 1Resistance Training 1Pulse Wave Analysis 1Prednisolone 1Palliative Care 1Observation 1Methods 1Lenalidomide 1Hematologic Tests 1Fenofibrate 1Exercise Test 1Environmental Biomarkers 1EGFR tyrosine kinase inhibitor 324674 1Dexrazoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiotoxicity × Tablets × 1 year × Clear all
NCT05559164 2025-11-14

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Rutgers, The State University of New Jersey

Phase 2 Recruiting
60 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡